7 Stocks ‘On Sale’ This Holiday Season

7 Stocks ‘On Sale’ This Holiday Season
Traders work on the floor of the New York Stock Exchange (NYSE) in New York on Oct. 25, 2021. (Spencer Platt/Getty Images)
Benzinga
11/26/2021
Updated:
11/26/2021

The SPDR S&P 500 ETF Trust has generated a total return of 26.4 percent year-to-date, but much of those overall gains have been driven by a handful of megacap stocks. In fact, 65 stocks in the S&P 500 are currently in the red year-to-date in 2021.

When a stock struggles in a bull market, it’s often an indication that there’s something fundamentally wrong with the underlying company’s business. However, sometimes market technicals, cyclicality, investor sentiment or even a healthy valuation reset can trigger temporary underperformance in high-quality stocks.

This time of year, it may feel like you’ve missed out on big rallies in the best stocks. But, there may still be a chance to buy some high-quality stocks for 2022 at a discount to what you would have paid a year ago.

But there’s a big difference between buying the dip in a quality stock and trying to catch a falling knife.

Benzinga screened for S&P 500 stocks that have consensus Buy ratings among Wall Street analysts, forward PE ratios of under 15 and year-to-date losses of at least 15 percent. Here are the seven stocks on sale that met those three criteria:
  • Global Payments Inc (GPN), year-to-date loss of 41.9 percent.
  • Viatris Inc (VTRS), year-to-date loss of 29.7 percent.
  • Incyte Corporation (INCY), year-to-date loss of 26.6 percent.
  • Fidelity National Information Servcs Inc (FIS), year-to-date loss of 23.1 percent.
  • Vertex Pharmaceuticals Incorporated (VRTX), year-to-date loss of 20.9 percent.
  • FleetCor Technologies, Inc. (FLT), year-to-date loss of 17.1 percent.
  • Fiserv Inc (FISV), year-to-date loss of 15.5 percent.
By Wayne Duggan
© 2021 The Epoch Times. The Epoch Times does not provide investment advice. All rights reserved.